Evorpacept
ASPEN-07
Phase 1 small_molecule completed
Quick answer
Evorpacept for Bladder Cancer is a Phase 1 program (small_molecule) at ALX ONCOLOGY HOLDINGS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALX ONCOLOGY HOLDINGS INC
- Indication
- Bladder Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed